In particular, targeting MUC5AC is of clinical relevance, as its overproduction has been implicated in severe muco-obstruction in COPD, whereas a marked suppression or loss of MUC5B secretion may impair host defence. Here, MUC5AC is linked to chronic obstructive pulmonary disease.